Palo Alto Networks (PANW) 10-Q 17 Nov 22 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Oct. 31, 2022	Nov. 10, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2022
Document Transition Report	false
Entity File Number	001-35594
Entity Registrant Name	PALO ALTO NETWORKS, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-2530195
Entity Address, Address Line One	3000 Tannery Way
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054
City Area Code	408
Local Phone Number	753-4000
Title of 12(b) Security	Common stock, $0.0001 par value per share
Trading Symbol	PANW
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Small Business	false
Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		302,356,927
Entity Central Index Key	0001327567
Document Fiscal Year End Date	--07-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Oct. 31, 2022	Jul. 31, 2022
Current assets:
Cash and cash equivalents	$ 2,067.2	$ 2,118.5
Short-term investments	1,736.5	1,516
Accounts receivable, net of allowance for credit losses of $8.4 and $8.9 at October 31, 2022 and July 31, 2022, respectively	1,238.1	2,142.5
Short-term deferred contract costs	310.6	317.7
Prepaid expenses and other current assets	381.1	320.2
Total current assets	5,733.5	6,414.9
Property and equipment, net	353.7	357.8
Operating lease right-of-use assets	260.4	242
Long-term investments	2,094.7	1,051.9
Long-term deferred contract costs	520.3	550.1
Goodwill	2,747.7	2,747.7
Intangible assets, net	355.4	384.5
Other assets	478.1	504.7
Total assets	12,543.8	12,253.6
Current liabilities:
Accounts payable	125.9	128
Accrued compensation	268.9	461.1
Accrued and other liabilities	380.4	399.2
Deferred revenue	3,741.3	3,641.2
Convertible senior notes, net	3,678.6	3,676.8
Total current liabilities	8,195.1	8,306.3
Long-term deferred revenue	3,438.3	3,352.8
Long-term operating lease liabilities	283.1	276.1
Other long-term liabilities	119.3	108.4
Liabilities	12,035.8	12,043.6
Commitments and contingencies (Note $9)
Stockholders’ equity:
Preferred stock; $0.0001 par value; 100.0 shares authorized; none issued and outstanding at October 31, 2022 and July 31, 2022	0	0
Common stock and additional paid-in capital; $0.0001 par value; 1,000.0 shares authorized; 302.3 and 298.8 shares issued and outstanding at October 31, 2022 and July 31, 2022, respectively	2,266.2	1,932.7
Accumulated other comprehensive loss	(111.1)	(55.6)
Accumulated deficit	(1,647.1)	(1,667.1)
Total stockholders’ equity	508	210
Total liabilities and stockholders’ equity	$ 12,543.8	$ 12,253.6

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Oct. 31, 2022	Jul. 31, 2022
Current assets:
Allowance for doubtful accounts	$ 8.4	$ 8.9
Stockholders’ equity:
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	302,300,000	298,800,000
Common stock, shares outstanding (in shares)	302,300,000	298,800,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Revenue:
Revenue:	$ 1,563.4	$ 1,247.4
Cost of revenue:
Cost of revenue:	461.9	380.6
Total gross profit	1,101.5	866.8
Operating expenses:
Research and development	371.8	339.5
Sales and marketing	615	505.9
General and administrative	99.5	104.1
Total operating expenses	1,086.3	949.5
Operating income (loss)	15.2	(82.7)
Interest expense	(6.8)	(6.9)
Other income (expense), net	26	(1.6)
Income (loss) before income taxes	34.4	(91.2)
Provision for income taxes	14.4	12.4
Net income (loss)	$ 20	$ (103.6)
Net income (loss) per share, basic (in usd per share)	$ 0.07	$ (0.35)
Net income (loss) per share, diluted (in usd per share)	$ 0.06	$ (0.35)
Weighted-average shares used to compute net income (loss) per share, basic (in shares)	299.8	292.9
Weighted-average shares used to compute net income (loss) per share, diluted (in shares)	338.4	292.9
Product
Revenue:
Revenue:	$ 330	$ 295.5
Cost of revenue:
Cost of revenue:	120.1	88.9
Subscription and support
Revenue:
Revenue:	1,233.4	951.9
Cost of revenue:
Cost of revenue:	$ 341.8	$ 291.7

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 20	$ (103.6)
Other comprehensive income (loss), net of tax:
Change in unrealized gains (losses) on investments	(27.8)	(2.2)
Change in unrealized gains (losses)	(42.5)	(1.9)
Net realized (gains) losses reclassified into earnings	14.8	2.7
Net change on cash flow hedges	(27.7)	0.8
Other comprehensive loss	(55.5)	(1.4)
Comprehensive loss	$ (35.5)	$ (105)

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Cumulative-effect adjustment from adoption of new accounting pronouncement	Common stock	Common stock and additional paid in capital	Common stock and additional paid in capital Cumulative-effect adjustment from adoption of new accounting pronouncement	Accumulated other comprehensive income (loss)	Accumulated deficit	Accumulated deficit Cumulative-effect adjustment from adoption of new accounting pronouncement
Common stock, beginning balance (in shares) at Jul. 31, 2021			291,900,000
Beginning balance at Jul. 31, 2021	$ 634.5	$ (315.2)		$ 2,311.2	$ (581.9)	$ (9.9)	$ (1,666.8)	$ 266.7
Increase (decrease) in stockholders' equity
Net income (loss)	(103.6)						(103.6)
Other comprehensive loss	(1.4)					(1.4)
Issuance of common stock in connection with employee equity incentive plans (in shares)			4,100,000
Issuance of common stock in connection with employee equity incentive plans	58.9			58.9
Taxes paid related to net share settlement of equity awards	(20)			(20)
Share-based compensation for equity-based awards	265.7			265.7
Common stock, ending balance (in shares) at Oct. 31, 2021			296,000,000
Ending balance at Oct. 31, 2021	$ 518.9			2,033.9		(11.3)	(1,503.7)
Common stock, beginning balance (in shares) at Jul. 31, 2022	298,800,000		298,800,000
Beginning balance at Jul. 31, 2022	$ 210			1,932.7		(55.6)	(1,667.1)
Increase (decrease) in stockholders' equity
Net income (loss)	20						20
Other comprehensive loss	(55.5)					(55.5)
Issuance of common stock in connection with employee equity incentive plans (in shares)			3,500,000
Issuance of common stock in connection with employee equity incentive plans	68.2			68.2
Taxes paid related to net share settlement of equity awards	(13.9)			(13.9)
Share-based compensation for equity-based awards	$ 279.2			279.2
Common stock, ending balance (in shares) at Oct. 31, 2022	302,300,000		302,300,000
Ending balance at Oct. 31, 2022	$ 508			$ 2,266.2		$ (111.1)	$ (1,647.1)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Cash flows from operating activities
Net income (loss)	$ 20	$ (103.6)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Share-based compensation for equity-based awards	266	259.1
Depreciation and amortization	70.7	69
Amortization of deferred contract costs	97	85.9
Amortization of debt discount and debt issuance costs	1.8	1.8
Reduction of operating lease right-of-use assets	12.1	12.7
Amortization of investment premiums, net of accretion of purchase discounts	1.7	3.6
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable, net	904.4	428.4
Deferred contract costs	(60.1)	(63.8)
Prepaid expenses and other assets	(41.1)	(72.8)
Accounts payable	(1)	37.6
Accrued compensation	(192.3)	(179.8)
Accrued and other liabilities	(28.1)	(23.4)
Deferred revenue	185.6	134.2
Net cash provided by operating activities	1,236.7	588.9
Cash flows from investing activities
Purchases of investments	(2,112.8)	(439.1)
Proceeds from sales of investments	485	36.1
Proceeds from maturities of investments	347.6	225.1
Business acquisitions, net of cash acquired	0	(17.4)
Purchases of property, equipment, and other assets	(39.6)	(34.6)
Net cash used in investing activities	(1,319.8)	(229.9)
Cash flows from financing activities
Repurchases of common stock	(22.7)	0
Proceeds from sales of shares through employee equity incentive plans	67.7	58.7
Payments for taxes related to net share settlement of equity awards	(13.9)	(20)
Net cash provided by financing activities	31.1	38.7
Net increase (decrease) in cash, cash equivalents, and restricted cash	(52)	397.7
Cash, cash equivalents, and restricted cash - beginning of period	2,124.8	1,880.1
Cash, cash equivalents, and restricted cash - end of period	$ 2,072.8	$ 2,277.8

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Millions	Oct. 31, 2022	Oct. 31, 2021
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents	$ 2,067.2	$ 2,272.9
Total cash, cash equivalents, and restricted cash	2,072.8	2,277.8
Prepaid expenses and other current assets
Reconciliation of cash, cash equivalents, and restricted cash
Restricted cash	5.6	4.4
Other assets
Reconciliation of cash, cash equivalents, and restricted cash
Restricted cash	$ 0	$ 0.5

Description of Business and Sum

Description of Business and Summary of Significant Accounting Policies (Notes)	3 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Summary of Significant Accounting Policies	Description of Business and Summary of Significant Accounting Policies Description of Business Palo Alto Networks, Inc. (the “Company,” “we,” “us,” or “our”), headquartered in Santa Clara, California, was incorporated in March 2005 under the laws of the State of Delaware and commenced operations in April 2005. We empower enterprises, organizations, service providers, and government entities to secure their users, networks, clouds, and endpoints by delivering comprehensive cybersecurity backed by artificial intelligence and automation. Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”), consistent in all material respects with those applied in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022, filed with the Securities and Exchange Commission (“SEC”) on September 6, 2022. Our condensed consolidated financial statements include our accounts and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements are unaudited but include all adjustments of a normal recurring nature necessary for a fair presentation of our quarterly results. Our condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and the accompanying notes. We base our estimates on assumptions, both historical and forward looking, that we believe are reasonable. Actual results could differ materially from those estimates due to risks and uncertainties, including uncertainty in the current economic environment. Summary of Significant Accounting Policies There have been no material changes to our significant accounting policies as of and for the three months ended October 31, 2022, as compared to the significant accounting policies described in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022. Stock Split Effected in the Form of a Stock Dividend (“Stock Split”) On September 13, 2022, we executed a three-for-one stock split of our common stock, effected in the form of a stock dividend. The par value per share of our common stock remains unchanged at $0.001 per share after the Stock Split. All references made to share or per share amounts on the accompanying condensed consolidated financial statements and applicable disclosures have been retroactively adjusted to reflect the effects of the Stock Split.

Revenue (Notes)

Revenue (Notes)	3 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The following table presents revenue by geographic theater (in millions): Three Months Ended October 31, 2022 2021 Revenue: Americas United States $ 1,006.3 $ 811.7 Other Americas 64.4 55.0 Total Americas 1,070.7 866.7 Europe, the Middle East, and Africa (“EMEA”) 307.9 233.8 Asia Pacific and Japan (“APAC”) 184.8 146.9 Total revenue $ 1,563.4 $ 1,247.4 The following table presents revenue for groups of similar products and services (in millions): Three Months Ended October 31, 2022 2021 Revenue: Product $ 330.0 $ 295.5 Subscription and support Subscription 764.0 578.8 Support 469.4 373.1 Total subscription and support 1,233.4 951.9 Total revenue $ 1,563.4 $ 1,247.4 Deferred Revenue During the three months ended October 31, 2022 and 2021, we recognized approximately $1.1 billion and $840.0 million of revenue pertaining to amounts that were deferred as of July 31, 2022 and 2021, respectively. Remaining Performance Obligations Remaining performance obligations were $8.3 billion as of October 31, 2022, of which we expect to recognize as revenue approximately $4.2 billion over the next 12 months and the remainder thereafter.

Fair Value Measurements (Notes)

Fair Value Measurements (Notes)	3 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table presents our financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2022 and July 31, 2022 (in millions): October 31, 2022 July 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 933.2 $ — $ — $ 933.2 $ 1,205.2 $ — $ — $ 1,205.2 Certificates of deposit — 150.6 — 150.6 — 155.3 — 155.3 Commercial paper — 338.5 — 338.5 — 69.1 — 69.1 Corporate debt securities — 37.2 — 37.2 — 19.5 — 19.5 U.S. government and agency securities — 159.9 — 159.9 — 10.0 — 10.0 Non-U.S. government and agency securities — — — — — 5.1 — 5.1 Total cash equivalents 933.2 686.2 — 1,619.4 1,205.2 259.0 — 1,464.2 Short-term investments: Certificates of deposit — 213.0 — 213.0 — 116.4 — 116.4 Commercial paper — 288.3 — 288.3 — 79.0 — 79.0 Corporate debt securities — 661.4 — 661.4 — 505.0 — 505.0 U.S. government and agency securities — 546.9 — 546.9 — 798.2 — 798.2 Non-U.S. government and agency securities — 26.9 — 26.9 — 17.4 — 17.4 Total short-term investments — 1,736.5 — 1,736.5 — 1,516.0 — 1,516.0 Long-term investments: Corporate debt securities — 1,623.8 — 1,623.8 — 761.2 — 761.2 U.S. government and agency securities — 50.2 — 50.2 — 118.2 — 118.2 Non-U.S. government and agency securities — 52.0 — 52.0 — — — — Asset-backed securities — 368.7 — 368.7 — 172.5 — 172.5 Total long-term investments — 2,094.7 — 2,094.7 — 1,051.9 — 1,051.9 October 31, 2022 July 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Prepaid expenses and other current assets: Foreign currency forward contracts — 0.5 — 0.5 — 2.4 — 2.4 Total prepaid expenses and other current assets — 0.5 — 0.5 — 2.4 — 2.4 Other assets: Foreign currency forward contracts — 0.2 — 0.2 — 0.7 — 0.7 Total other assets — 0.2 — 0.2 — 0.7 — 0.7 Total assets measured at fair value $ 933.2 $ 4,518.1 $ — $ 5,451.3 $ 1,205.2 $ 2,830.0 $ — $ 4,035.2 Accrued and other liabilities: Foreign currency forward contracts $ — $ 51.4 $ — $ 51.4 $ — $ 32.4 $ — $ 32.4 Total accrued and other liabilities — 51.4 — 51.4 — 32.4 — 32.4 Other long-term liabilities: Foreign currency forward contracts — 5.2 — 5.2 — 0.8 — 0.8 Total other long-term liabilities — 5.2 — 5.2 — 0.8 — 0.8 Total liabilities measured at fair value $ — $ 56.6 $ — $ 56.6 $ — $ 33.2 $ — $ 33.2 Refer to Note 8. Debt for the carrying amount and estimated fair value of our convertible senior notes as of October 31, 2022 and July 31, 2022.

Cash Equivalents and Investment

Cash Equivalents and Investments (Notes)	3 Months Ended
	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Investments	Cash Equivalents and Investments Available-for-sale Debt Securities The following tables summarize the amortized cost, unrealized gains and losses, and fair value of our available-for-sale debt securities as of October 31, 2022 and July 31, 2022 (in millions): October 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Certificates of deposit $ 150.6 $ — $ — $ 150.6 Commercial paper 338.5 — — 338.5 Corporate debt securities 37.3 — (0.1) 37.2 U.S. government and agency securities 159.9 — — 159.9 Total available-for-sale cash equivalents $ 686.3 $ — $ (0.1) $ 686.2 Investments: Certificates of deposit $ 213.3 $ — $ (0.3) $ 213.0 Commercial paper 289.4 — (1.1) 288.3 Corporate debt securities 2,321.6 0.4 (36.8) 2,285.2 U.S. government and agency securities 605.3 — (8.2) 597.1 Non-U.S. government and agency securities 80.0 — (1.1) 78.9 Asset-backed securities 372.8 — (4.1) 368.7 Total available-for-sale investments $ 3,882.4 $ 0.4 $ (51.6) $ 3,831.2 July 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Certificates of deposit $ 155.3 $ — $ — $ 155.3 Commercial paper 69.1 — — 69.1 Corporate debt securities 19.5 — — 19.5 U.S. government and agency securities 10.0 — — 10.0 Non-U.S. government and agency securities 5.0 0.1 — 5.1 Total available-for-sale cash equivalents $ 258.9 $ 0.1 $ — $ 259.0 Investments: Certificates of deposit $ 116.5 $ — $ (0.1) $ 116.4 Commercial paper 79.1 — (0.1) 79.0 Corporate debt securities 1,276.8 1.3 (11.9) 1,266.2 U.S. government and agency securities 928.1 0.1 (11.8) 916.4 Non-U.S. government and agency securities 17.6 — (0.2) 17.4 Asset-backed securities $ 173.4 $ 0.2 $ (1.1) $ 172.5 Total available-for-sale investments $ 2,591.5 $ 1.6 $ (25.2) $ 2,567.9 As of October 31, 2022, the gross unrealized losses that have been in a continuous unrealized loss position for less than 12 months were $45.7 million, which were related to $3.5 billion of available-for-sale debt securities, and the gross unrealized losses that have been in a continuous unrealized loss position for more than 12 months were not material. As of July 31, 2022 the gross unrealized losses that have been in a continuous unrealized loss position for less than 12 months were $24.8 million, which were related to $2.0 billion of available-for-sale debt securities, and the gross unrealized losses that have been in a continuous unrealized loss position for more than 12 months were not material. Unrealized losses related to our available-for-sale debt securities are due to interest rate fluctuations as opposed to credit quality. We do not intend to sell any of the securities in an unrealized loss position and it is not likely that we would be required to sell these securities before recovery of their amortized cost basis, which may be at maturity. We did not recognize any credit losses related to our available-for-sale debt securities during the three months ended October 31, 2022 and 2021. The following table summarizes the amortized cost and fair value of our available-for-sale debt securities as of October 31, 2022, by contractual years-to-maturity (in millions): Amortized Cost Fair Value Due within one year $ 2,438.8 $ 2,422.7 Due between one and three years 2,001.9 1,968.5 Due between three to five years 106.9 105.4 Due between five to ten years 21.1 20.8 Total $ 4,568.7 $ 4,517.4 Marketable Equity Securities Marketable equity securities consist of money market funds and are included in cash and cash equivalents on our condensed consolidated balance sheets. As of October 31, 2022 and July 31, 2022, the carrying values of our marketable equity securities were $933.2 million and $1.2 billion, respectively. There were no unrealized gains or losses recognized for these securities during the three months ended October 31, 2022 and 2021.

Financing Receivables (Notes)

Financing Receivables (Notes)	3 Months Ended
	Oct. 31, 2022
Receivables [Abstract]
Financing Receivables	Financing Receivables The following table summarizes our short-term and long-term financing receivables as of October 31, 2022 and July 31, 2022 (in millions): October 31, 2022 July 31, 2022 Short-term financing receivables, gross $ 155.5 $ 112.6 Allowance for credit losses (1.8) (1.3) Short-term financing receivables, net $ 153.7 $ 111.3 Long-term financing receivables, gross $ 165.2 $ 194.6 Allowance for credit losses (3.1) (2.5) Long-term financing receivables, net $ 162.1 $ 192.1

Derivative Instruments (Notes)

Derivative Instruments (Notes)	3 Months Ended
	Oct. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments We are exposed to foreign currency exchange risk. Substantially all of our revenue is transacted in U.S. dollars, however, a portion of our operating expenditures are incurred outside of the United States and are denominated in foreign currencies, making them subject to fluctuations in foreign currency exchange rates. We enter into foreign currency derivative contracts with maturities of 24 months or less, which we designate as cash flow hedges, to manage the foreign currency exchange risk associated with our operating expenditures. As of October 31, 2022 and July 31, 2022, the total notional amount of our outstanding foreign currency forward contracts was $1.3 billion and $856.9 million, respectively. Refer to Note 3. Fair Value Measurements for the fair value of our derivative instruments as reported on our condensed consolidated balance sheets as of October 31, 2022 and July 31, 2022.

Intangible Assets (Notes)

Intangible Assets (Notes)	3 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Purchased Intangible Assets The following table presents details of our purchased intangible assets as of October 31, 2022 and July 31, 2022 (in millions): October 31, 2022 July 31, 2022 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Intangible assets subject to amortization: Developed technology $ 600.7 $ (371.2) $ 229.5 $ 600.7 $ (347.9) $ 252.8 Customer relationships 172.7 (57.7) 115.0 172.7 (52.2) 120.5 Acquired intellectual property 11.3 (5.0) 6.3 11.3 (4.8) 6.5 Trade name and trademarks 9.4 (9.4) — 9.4 (9.4) — Other 0.9 (0.2) 0.7 0.9 (0.1) 0.8 Total intangible assets subject to amortization 795.0 (443.5) 351.5 795.0 (414.4) 380.6 Intangible assets not subject to amortization: In-process research and development 3.9 — 3.9 3.9 — 3.9 Total purchased intangible assets $ 798.9 $ (443.5) $ 355.4 $ 798.9 $ (414.4) $ 384.5 We recognized amortization expense of $29.1 million and $31.8 million for the three months ended October 31, 2022 and 2021, respectively. The following table summarizes estimated future amortization expense of our intangible assets subject to amortization as of October 31, 2022 (in millions): Fiscal years ending July 31, Total Remaining 2023 2024 2025 2026 2027 2028 and Thereafter Future amortization expense $ 351.5 $ 72.0 $ 91.1 $ 77.4 $ 55.6 $ 28.5 $ 26.9

Debt (Notes)

Debt (Notes)	3 Months Ended
	Oct. 31, 2022
Debt Disclosure [Abstract]
Debt	Debt Convertible Senior Notes In July 2018, we issued $1.7 billion aggregate principal amount of 0.75% Convertible Senior Notes due 2023 (the “2023 Notes”) and in June 2020, we issued $2.0 billion aggregate principal amount of 0.375% Convertible Senior Notes due 2025 (the “2025 Notes,” and together with the 2023 Notes, the “Notes”). The 2023 Notes bear interest at a fixed rate of 0.75% per year, payable semi-annually in arrears on January 1 and July 1 of each year, beginning on January 1, 2019. The 2025 Notes bear interest at a fixed rate of 0.375% per year, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. Each series of the convertible notes is governed by an indenture between us, as the issuer, and U.S. Bank National Association, as Trustee (individually, each an “Indenture,” and together, the “Indentures”). The Notes of each series are unsecured, unsubordinated obligations and the applicable Indenture governing each series of Notes does not contain any financial covenants or restrictions on the payments of dividends, the incurrence of indebtedness, or the issuance or repurchase of securities by us or any of our subsidiaries. The 2023 Notes and the 2025 Notes mature on July 1, 2023 and June 1, 2025, respectively. We cannot redeem the 2023 Notes prior to maturity. We may redeem for cash all or any portion of the 2025 Notes, at our option, on or after June 5, 2023, and prior to the 31st scheduled trading day immediately preceding the maturity date if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period ending on and including the trading day preceding the date on which we provide notice of redemption. The redemption will be at a price equal to 100% of the principal amount of the 2025 Notes and adjusted for interest. If we call any or all of the 2025 Notes for redemption, holders may convert such 2025 Notes called for redemption at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date. The following table presents details of our Notes (number of shares in millions): Conversion Rate per $1,000 Principal Initial Conversion Price Convertible Date Initial Number of Shares 2023 Notes 11.2635 $ 88.78 April 1, 2023 19.1 2025 Notes 10.0806 $ 99.20 March 1, 2025 20.1 Holders of the Notes may surrender their Notes for conversion at their option at any time prior to the close of business on the business day immediately preceding their respective convertible dates only under the following circumstances: • during any fiscal quarter commencing after the fiscal quarters ending on October 31, 2018 and October 31, 2020 for the 2023 Notes and the 2025 Notes, respectively (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the respective Notes on each applicable trading day (the “sale price condition”); • during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the applicable series of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the applicable conversion rate for the respective Notes on each such trading day; or • upon the occurrence of specified corporate events. On or after the respective convertible date, holders may surrender all or any portion of their Notes for conversion at any time prior to the close of business on the second scheduled trading day immediately preceding the applicable maturity date regardless of the foregoing conditions, and such conversions will be settled upon the applicable maturity date. Upon conversion, holders of the Notes of a series will receive cash equal to the aggregate principal amount of the Notes of such series to be converted, and, at our election, cash and/or shares of our common stock for any amounts in excess of the aggregate principal amount of the Notes of such series being converted. The conversion price will be subject to adjustment in some events. Holders of the Notes of a series who convert their Notes of such series in connection with certain corporate events that constitute a “make-whole fundamental change” under the applicable Indenture are, under certain circumstances, entitled to an increase in the conversion rate for such series of Notes. Additionally, upon the occurrence of a corporate event that constitutes a “fundamental change” under the applicable Indenture, holders of the Notes of such series may require us to repurchase for cash all or a portion of the Notes of such series at a repurchase price equal to 100% of the principal amount of the Notes of such series plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The sale price condition for the Notes was met during the fiscal quarter ended October 31, 2022, and as a result, holders may convert their Notes at any time during the fiscal quarter ending January 31, 2023. The net carrying amount of the Notes was classified as a current liability on our condensed consolidated balance sheet as of October 31, 2022. The following table sets forth the components of the Notes (in millions): October 31, 2022 July 31, 2022 2023 Notes 2025 Notes Total 2023 Notes 2025 Notes Total Liability component: Principal $ 1,691.9 $ 1,999.4 $ 3,691.3 $ 1,691.9 $ 1,999.4 $ 3,691.3 Less: debt discount and debt issuance costs, net of amortization (1.9) (10.8) (12.7) (2.6) (11.9) (14.5) Net carrying amount $ 1,690.0 $ 1,988.6 $ 3,678.6 $ 1,689.3 $ 1,987.5 $ 3,676.8 The total estimated fair value of the 2023 Notes and 2025 Notes were $3.3 billion and $3.5 billion at October 31, 2022, respectively, and $3.2 billion and $3.5 billion at July 31, 2022, respectively. The fair value was determined based on the closing trading price per $100 of the applicable series of the Notes as of the last day of trading for the period. We consider the fair value of the Notes at October 31, 2022 and July 31, 2022 to be a Level 2 measurement. The fair value of the Notes is primarily affected by the trading price of our common stock and market interest rates. The following table sets forth interest expense recognized related to the Notes (dollars in millions): Three Months Ended October 31, 2022 2021 2023 Notes 2025 Notes Total 2023 Notes 2025 Notes Total Contractual interest expense $ 3.2 $ 1.8 $ 5.0 $ 3.2 $ 1.9 $ 5.1 Amortization of debt issuance costs 0.7 1.1 1.8 0.7 1.1 1.8 Total interest expense $ 3.9 $ 2.9 $ 6.8 $ 3.9 $ 3.0 $ 6.9 Effective interest rate 0.9 % 0.6 % 0.9 % 0.6 % Note Hedges To minimize the impact of potential economic dilution upon conversion of our Notes, we entered into separate convertible note hedge transactions (the “2023 Note Hedges,” with respect to the 2023 Notes, the “2025 Note Hedges,” with respect to the 2025 Notes, and the 2023 Notes Hedges together with 2025 Note Hedges, the “Note Hedges”) with respect to our common stock concurrent with the issuance of each series of the Notes. The following table presents details of our Note Hedges (in millions): Initial Number of Shares Aggregate Purchase 2023 Note Hedges 19.1 $ 332.0 2025 Note Hedges 20.1 $ 370.8 The Note Hedges cover shares of our common stock at a strike price per share that corresponds to the initial applicable conversion price of the applicable series of the Notes, which are also subject to adjustment, and are exercisable upon conversion of the applicable series of the Notes. The Note Hedges will expire upon maturity of the applicable series of the Notes. The Note Hedges are separate transactions and are not part of the terms of the applicable series of the Notes. Holders of the Notes of either series will not have any rights with respect to the Note Hedges. Any shares of our common stock receivable by us under the Note Hedges are excluded from the calculation of diluted earnings per share as they are antidilutive. The aggregate amounts paid for the Note Hedges are included in additional paid-in capital on our condensed consolidated balance sheets. Warrants Separately, but concurrently with the issuance of each series of our Notes, we entered into transactions whereby we sold warrants (the “2023 Warrants,” with respect to the 2023 Notes, the “2025 Warrants,” with respect to the 2025 Notes, and the 2023 Warrants together with the 2025 Warrants, the “Warrants”) to acquire shares of our common stock, subject to anti-dilution adjustments. The 2023 Warrants and 2025 Warrants are exercisable beginning October 2023 and September 2025, respectively. The following table presents details of our Warrants (in millions, except per share data): Initial Number Strike Price Aggregate 2023 Warrants 19.1 $ 139.27 $ 145.4 2025 Warrants 20.1 $ 136.16 $ 202.8 The shares issuable under the Warrants will be included in the calculation of diluted earnings per share when the average market value per share of our common stock for the reporting period exceeds the applicable strike price for such series of Warrants. The Warrants are separate transactions and are not part of either series of Notes or Note Hedges and are not remeasured through earnings each reporting period. Holders of the Notes of either series will not have any rights with respect to the Warrants. The aggregate proceeds received from the sale of the Warrants are included in additional paid-in capital on our condensed consolidated balance sheets. Revolving Credit Facility On September 4, 2018, we entered into a credit agreement (the “Credit Agreement”) with certain institutional lenders that provides for a $400.0 million unsecured revolving credit facility (the “Credit Facility”), with an option to increase the amount of the Credit Facility by up to an additional $350.0 million, subject to certain conditions. The Credit Facility matures on the earlier of (i) September 4, 2023 and (ii) the date that is 91 days prior to the stated maturity of our 2023 Notes if (a) any of the 2023 Notes are still outstanding and (b) our unrestricted cash and cash equivalents are less than the then outstanding principal amount of our 2023 Notes plus $400.0 million. The borrowings under the Credit Facility currently bear interest, at our option, at a base rate plus a spread of 0.00% to 0.75%, or an adjusted LIBO Rate plus a spread of 1.00% to 1.75%, in each case with such spread being determined based on our leverage ratio. We are obligated to pay an ongoing commitment fee on undrawn amounts at a rate of 0.125% to 0.250%, depending on our leverage ratio. In March 2021, the ICE Benchmark Administration, the administrator of LIBO Rate, announced that it will cease publication of the LIBO Rate by June 2023. Under the terms of our Credit Facility, in the event of the discontinuance of the LIBO Rate, a mutually agreed-upon alternative benchmark rate will be established to replace the LIBO Rate, which may include the Secured Overnight Financing Rate (“SOFR”). We do not anticipate that the discontinuance of the LIBO Rate will materially impact our liquidity or financial position. As of October 31, 2022, there were no amounts outstanding and we were in compliance with all covenants under the Credit Agreement.

Commitments and Contingencies (

Commitments and Contingencies (Notes)	3 Months Ended
	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Commitments Manufacturing Purchase Commitments In order to reduce manufacturing lead times and plan for adequate supply, we enter into agreements with manufacturing partners and component suppliers to procure inventory based on our demand forecasts. The following table presents details of the aggregate future minimum or fixed purchase commitments under these arrangements, excluding obligations under contracts that we can cancel as of October 31, 2022 (in millions): Fiscal years ending July 31, Total Remaining 2023 2024 2025 2026 2027 2028 and Thereafter Manufacturing purchase commitments $ 319.7 $ 189.7 $ 55.0 $ 35.0 $ 40.0 $ — $ — Other Purchase Commitments We have entered into various non-cancelable agreements with certain service providers, under which we are committed to minimum or fixed purchases. The following table presents details of the aggregate future non-cancelable purchase commitments under these agreements as of October 31, 2022 (in millions): Fiscal years ending July 31, Total Remaining 2023 2024 2025 2026 2027 2028 and Thereafter Other purchase commitments $ 1,801.4 $ 58.1 $ 357.6 $ 413.9 $ 516.3 $ 454.7 $ 0.8 Additionally, we have a $160.6 million minimum purchase commitment with a service provider through September 2027 with no specified annual commitments. Litigation We are subject to legal proceedings, claims, and litigation arising in the ordinary course of business, including intellectual property litigation. Such matters are subject to many uncertainties and outcomes are not predictable with assurance. We accrue for contingencies when we believe that a loss is probable and that we can reasonably estimate the amount of any such loss. To the extent there is a reasonable possibility that a loss exceeding amounts already recognized may be incurred and the amount of such additional loss would be material, we will either disclose the estimated additional loss or state that such an estimate cannot be made. As of October 31, 2022, we have not recorded any significant accruals for loss contingencies associated with such legal proceedings, determined that an unfavorable outcome is probable or reasonably possible, or determined that the amount or range of any possible loss is reasonably estimable.

Stockholders' Equity (Notes)

Stockholders' Equity (Notes)	3 Months Ended
	Oct. 31, 2022
Equity [Abstract]
Stockholders’ Equity	Stockholders’ Equity Share Repurchase Program In February 2019, our board of directors authorized a $1.0 billion share repurchase program, which is funded from available working capital. In December 2020, August 2021, and August 2022, our board of directors authorized additional $700.0 million, $676.1 million, and $915.0 million increases to this share repurchase program, respectively, bringing the total authorization under this share repurchase program to $3.3 billion (our “current authorization”). The expiration date of our current authorization was extended to December 31, 2023, and our repurchase program may be suspended or discontinued at any time. Repurchases may be made at management’s discretion from time to time on the open market, through privately negotiated transactions, transactions structured through investment banking institutions, block purchase techniques, 10b5-1 trading plans, or a combination of the foregoing. We did not repurchase shares of our common stock during the three months ended October 31, 2022 and 2021. During the three months ended October 31, 2022, we paid $22.7 million related to share repurchases of our common stock that were not settled as of July 31, 2022. As of October 31, 2022, $1.0 billion remained available for future share repurchases under our current repurchase authorization. The total price of the shares repurchased and related transaction costs are reflected as a reduction to common stock and additional paid-in capital on our condensed consolidated balance sheets.

Equity Award Plans (Notes)

Equity Award Plans (Notes)	3 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Equity Award Plans	Equity Award Plans Restricted Stock Unit (“RSU”) and Performance-Based Stock Unit (“PSU”) Activities The following table summarizes the RSU and PSU activity under our stock plans during the three months ended October 31, 2022 (in millions, except per share amounts): RSUs Outstanding PSUs Outstanding Number of Shares Weighted-Average Grant-Date Fair Value Per Share Aggregate Intrinsic Value Number of Shares Weighted-Average Grant-Date Fair Value Per Share Aggregate Intrinsic Value Balance—July 31, 2022 14.8 $ 115.51 $ 2,456.9 3.1 $ 106.38 $ 513.7 Granted (1) 1.0 $ 174.04 2.6 $ 140.41 Vested (1.9) $ 99.25 (1.1) $ 117.42 Forfeited (0.4) $ 113.23 (0.1) $ 124.01 Balance—October 31, 2022 13.5 $ 122.57 $ 2,311.7 4.5 $ 123.10 $ 772.7 ______________ (1) For PSUs, shares granted represent the aggregate maximum number of shares that may be earned and issued with respect to these awards over their full terms. Our RSUs generally vest over a period of three Our PSUs generally vest over a period of one During the three months ended October 31, 2022, we granted 0.8 million shares of PSUs with both service and market conditions to certain employees. The market conditions are satisfied when the price of our common stock is equal to or exceeds stock price targets of $233.33, $266.67, $300.00, and $333.33 based on the average closing price for 30 consecutive trading days during the three During the three months ended October 31, 2022 and 2021, we granted 1.6 million and 0.6 million shares of PSUs, respectively, which contain service, performance and market conditions, to certain employees. The service conditions are satisfied over a period of one The fair value of the PSUs subject to market conditions is estimated on the grant date using a Monte Carlo simulation model. The following table summarizes the assumptions used and the grant-date fair value of these PSUs granted: Three Months Ended October 31, 2022 2021 Volatility 39.6% - 44.8% 36.0% - 38.0% Expected term (in years) 1.0 - 4.0 1.9 - 3.0 Dividend yield 0.0 % 0.0 % Risk-free interest rate 3.2% - 3.6% 0.2% - 0.4% Grant-date fair value per share $105.60 - $280.41 $137.16 - $140.22 Performance Stock Option (“PSO”) Activities We have granted PSOs with both service and market conditions to certain executives. The market conditions were achieved when certain stock price targets were met. As of October 31, 2022, all stock price targets for our outstanding PSOs have been satisfied. One-fourth of the PSOs will vest on each anniversary date of the grant date, subject to continued service. The contractual term for the PSOs outstanding ranges from seven The following table summarizes the PSO activity under our stock plans during the three months ended October 31, 2022 (in millions, except per share amounts): PSOs Outstanding Number of Shares Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Balance—July 31, 2022 8.0 $ 64.85 3.2 $ 809.3 Balance—October 31, 2022 8.0 $ 64.85 2.9 $ 851.0 Exercisable—October 31, 2022 8.0 $ 64.85 2.9 $ 851.0 Share-Based Compensation The following table summarizes share-based compensation included in costs and expenses (in millions): Three Months Ended October 31, 2022 2021 Cost of product revenue $ 2.4 $ 2.3 Cost of subscription and support revenue 28.8 26.7 Research and development 118.0 125.6 Sales and marketing 87.4 73.3 General and administrative 29.4 32.4 Total share-based compensation $ 266.0 $ 260.3 As of October 31, 2022, total compensation cost related to unvested share-based awards not yet recognized was $2.0 billion. This cost is expected to be amortized over a weighted-average period of approximately 2.5 years .

Income Taxes (Notes)

Income Taxes (Notes)	3 Months Ended
	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three months ended October 31, 2022 and 2021, our provision for income taxes reflected an effective tax rate of 41.9% and negative 13.6%, respectively. Our income taxes for the three months ended October 31, 2022 were primarily due to U.S. taxes, withholding taxes, and foreign income taxes. Our effective tax rate increased compared to the same period last year primarily due to an increase in current U.S. taxes as a result of mandatory capitalization and amortization of research and development expenditures incurred in fiscal year 2023, as required by the 2017 Tax Cuts and Jobs Act (“TCJA”). There is no offsetting deferred benefit due to our valuation allowance. Our income taxes for the three months ended October 31, 2021 were primarily due to foreign income taxes and withholding taxes. Our effective tax rates differed from the U.S. statutory tax rate primarily due to changes in our valuation allowance.

Net Income (Loss) Per Share (No

Net Income (Loss) Per Share (Notes)	3 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income (loss) by basic weighted-average shares outstanding during the period. Diluted net income (loss) per share is computed by dividing net income (loss) by diluted weighted-average shares outstanding during the period giving effect to all potentially dilutive securities to the extent they are dilutive. Potentially dilutive securities include shares issuable upon conversion of our convertible senior notes using the if-converted method. Potentially dilutive securities also include warrants related to the issuance of convertible senior notes and equity awards under our employee equity incentive plans using the treasury stock method. The following table presents the computation of basic and diluted net income (loss) per share of common stock (in millions, except per share data): Three Months Ended October 31, 2022 2021 Net income (loss) $ 20.0 $ (103.6) Weighted-average shares used to compute net income (loss) per share, basic 299.8 292.9 Weighted-average effect of potentially dilutive securities: Convertible senior notes 17.8 — Warrants related to the issuance of convertible senior notes 7.8 — Employee equity incentive plans 13.0 — Weighted-average shares used to compute net income (loss) per share, diluted 338.4 292.9 Net income (loss) per share, basic $ 0.07 $ (0.35) Net income (loss) per share, diluted $ 0.06 $ (0.35) The following securities were excluded from the computation of diluted net income (loss) per share of common stock as their effect would have been antidilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the applicable period (in millions): Three Months Ended October 31, 2022 2021 Convertible senior notes — 39.2 Warrants related to the issuance of convertible senior notes — 39.2 Employee equity incentive plans 2.7 34.5 Total 2.7 112.9

Other Income (Expense), Net (No

Other Income (Expense), Net (Notes)	3 Months Ended
	Oct. 31, 2022
Other Income and Expenses [Abstract]
Other Income (Expense), Net	Other Income (Expense), Net The following table sets forth the components of other income (expense), net (in millions): Three Months Ended October 31, 2022 2021 Interest income $ 29.4 $ 1.4 Foreign currency exchange gains (losses), net 4.4 (3.9) Other (7.8) 0.9 Total other income (expense), net $ 26.0 $ (1.6)

Subsequent Event (Notes)

Subsequent Event (Notes)	3 Months Ended
	Oct. 31, 2022
Subsequent Events [Abstract]
Subsequent Event	Subsequent Event Business Combination On November 17, 2022, we entered into a definitive agreement to acquire Cider Security Ltd., a privately-held cyber security company, for total consideration of approximately $250.0 million, including approximately $194.6 million in cash and approximately $55.4 million in replacement equity awards, subject to adjustment. We expect the acquisition will support Prisma Cloud’s platform approach to securing the entire application security lifecycle from code-to-cloud. The proposed acquisition is expected to close during our second quarter of fiscal 2023, subject to the satisfaction of customary closing conditions.

Description of Business and S_2

Description of Business and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”), consistent in all material respects with those applied in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022, filed with the Securities and Exchange Commission (“SEC”) on September 6, 2022. Our condensed consolidated financial statements include our accounts and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements are unaudited but include all adjustments of a normal recurring nature necessary for a fair presentation of our quarterly results. Our condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and the accompanying notes. We base our estimates on assumptions, both historical and forward looking, that we believe are reasonable. Actual results could differ materially from those estimates due to risks and uncertainties, including uncertainty in the current economic environment.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue from external customers by geographic areas	The following table presents revenue by geographic theater (in millions): Three Months Ended October 31, 2022 2021 Revenue: Americas United States $ 1,006.3 $ 811.7 Other Americas 64.4 55.0 Total Americas 1,070.7 866.7 Europe, the Middle East, and Africa (“EMEA”) 307.9 233.8 Asia Pacific and Japan (“APAC”) 184.8 146.9 Total revenue $ 1,563.4 $ 1,247.4
Revenue from external customers by products and services	The following table presents revenue for groups of similar products and services (in millions): Three Months Ended October 31, 2022 2021 Revenue: Product $ 330.0 $ 295.5 Subscription and support Subscription 764.0 578.8 Support 469.4 373.1 Total subscription and support 1,233.4 951.9 Total revenue $ 1,563.4 $ 1,247.4

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of fair value of financial assets and liabilities	The following table presents our financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2022 and July 31, 2022 (in millions): October 31, 2022 July 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 933.2 $ — $ — $ 933.2 $ 1,205.2 $ — $ — $ 1,205.2 Certificates of deposit — 150.6 — 150.6 — 155.3 — 155.3 Commercial paper — 338.5 — 338.5 — 69.1 — 69.1 Corporate debt securities — 37.2 — 37.2 — 19.5 — 19.5 U.S. government and agency securities — 159.9 — 159.9 — 10.0 — 10.0 Non-U.S. government and agency securities — — — — — 5.1 — 5.1 Total cash equivalents 933.2 686.2 — 1,619.4 1,205.2 259.0 — 1,464.2 Short-term investments: Certificates of deposit — 213.0 — 213.0 — 116.4 — 116.4 Commercial paper — 288.3 — 288.3 — 79.0 — 79.0 Corporate debt securities — 661.4 — 661.4 — 505.0 — 505.0 U.S. government and agency securities — 546.9 — 546.9 — 798.2 — 798.2 Non-U.S. government and agency securities — 26.9 — 26.9 — 17.4 — 17.4 Total short-term investments — 1,736.5 — 1,736.5 — 1,516.0 — 1,516.0 Long-term investments: Corporate debt securities — 1,623.8 — 1,623.8 — 761.2 — 761.2 U.S. government and agency securities — 50.2 — 50.2 — 118.2 — 118.2 Non-U.S. government and agency securities — 52.0 — 52.0 — — — — Asset-backed securities — 368.7 — 368.7 — 172.5 — 172.5 Total long-term investments — 2,094.7 — 2,094.7 — 1,051.9 — 1,051.9 October 31, 2022 July 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Prepaid expenses and other current assets: Foreign currency forward contracts — 0.5 — 0.5 — 2.4 — 2.4 Total prepaid expenses and other current assets — 0.5 — 0.5 — 2.4 — 2.4 Other assets: Foreign currency forward contracts — 0.2 — 0.2 — 0.7 — 0.7 Total other assets — 0.2 — 0.2 — 0.7 — 0.7 Total assets measured at fair value $ 933.2 $ 4,518.1 $ — $ 5,451.3 $ 1,205.2 $ 2,830.0 $ — $ 4,035.2 Accrued and other liabilities: Foreign currency forward contracts $ — $ 51.4 $ — $ 51.4 $ — $ 32.4 $ — $ 32.4 Total accrued and other liabilities — 51.4 — 51.4 — 32.4 — 32.4 Other long-term liabilities: Foreign currency forward contracts — 5.2 — 5.2 — 0.8 — 0.8 Total other long-term liabilities — 5.2 — 5.2 — 0.8 — 0.8 Total liabilities measured at fair value $ — $ 56.6 $ — $ 56.6 $ — $ 33.2 $ — $ 33.2

Cash Equivalents and Investme_2

Cash Equivalents and Investments (Tables)	3 Months Ended
	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of available-for-sale debt securities	The following tables summarize the amortized cost, unrealized gains and losses, and fair value of our available-for-sale debt securities as of October 31, 2022 and July 31, 2022 (in millions): October 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Certificates of deposit $ 150.6 $ — $ — $ 150.6 Commercial paper 338.5 — — 338.5 Corporate debt securities 37.3 — (0.1) 37.2 U.S. government and agency securities 159.9 — — 159.9 Total available-for-sale cash equivalents $ 686.3 $ — $ (0.1) $ 686.2 Investments: Certificates of deposit $ 213.3 $ — $ (0.3) $ 213.0 Commercial paper 289.4 — (1.1) 288.3 Corporate debt securities 2,321.6 0.4 (36.8) 2,285.2 U.S. government and agency securities 605.3 — (8.2) 597.1 Non-U.S. government and agency securities 80.0 — (1.1) 78.9 Asset-backed securities 372.8 — (4.1) 368.7 Total available-for-sale investments $ 3,882.4 $ 0.4 $ (51.6) $ 3,831.2 July 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Certificates of deposit $ 155.3 $ — $ — $ 155.3 Commercial paper 69.1 — — 69.1 Corporate debt securities 19.5 — — 19.5 U.S. government and agency securities 10.0 — — 10.0 Non-U.S. government and agency securities 5.0 0.1 — 5.1 Total available-for-sale cash equivalents $ 258.9 $ 0.1 $ — $ 259.0 Investments: Certificates of deposit $ 116.5 $ — $ (0.1) $ 116.4 Commercial paper 79.1 — (0.1) 79.0 Corporate debt securities 1,276.8 1.3 (11.9) 1,266.2 U.S. government and agency securities 928.1 0.1 (11.8) 916.4 Non-U.S. government and agency securities 17.6 — (0.2) 17.4 Asset-backed securities $ 173.4 $ 0.2 $ (1.1) $ 172.5 Total available-for-sale investments $ 2,591.5 $ 1.6 $ (25.2) $ 2,567.9
Schedule of contractual maturities of available-for-sale debt securities	The following table summarizes the amortized cost and fair value of our available-for-sale debt securities as of October 31, 2022, by contractual years-to-maturity (in millions): Amortized Cost Fair Value Due within one year $ 2,438.8 $ 2,422.7 Due between one and three years 2,001.9 1,968.5 Due between three to five years 106.9 105.4 Due between five to ten years 21.1 20.8 Total $ 4,568.7 $ 4,517.4

Financing Receivables (Tables)

Financing Receivables (Tables)	3 Months Ended
	Oct. 31, 2022
Receivables [Abstract]
Short- and long-term financing receivables	The following table summarizes our short-term and long-term financing receivables as of October 31, 2022 and July 31, 2022 (in millions): October 31, 2022 July 31, 2022 Short-term financing receivables, gross $ 155.5 $ 112.6 Allowance for credit losses (1.8) (1.3) Short-term financing receivables, net $ 153.7 $ 111.3 Long-term financing receivables, gross $ 165.2 $ 194.6 Allowance for credit losses (3.1) (2.5) Long-term financing receivables, net $ 162.1 $ 192.1

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of purchased finite-lived intangible assets by major class	The following table presents details of our purchased intangible assets as of October 31, 2022 and July 31, 2022 (in millions): October 31, 2022 July 31, 2022 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Intangible assets subject to amortization: Developed technology $ 600.7 $ (371.2) $ 229.5 $ 600.7 $ (347.9) $ 252.8 Customer relationships 172.7 (57.7) 115.0 172.7 (52.2) 120.5 Acquired intellectual property 11.3 (5.0) 6.3 11.3 (4.8) 6.5 Trade name and trademarks 9.4 (9.4) — 9.4 (9.4) — Other 0.9 (0.2) 0.7 0.9 (0.1) 0.8 Total intangible assets subject to amortization 795.0 (443.5) 351.5 795.0 (414.4) 380.6 Intangible assets not subject to amortization: In-process research and development 3.9 — 3.9 3.9 — 3.9 Total purchased intangible assets $ 798.9 $ (443.5) $ 355.4 $ 798.9 $ (414.4) $ 384.5
Future amortization expense of intangible assets	The following table summarizes estimated future amortization expense of our intangible assets subject to amortization as of October 31, 2022 (in millions): Fiscal years ending July 31, Total Remaining 2023 2024 2025 2026 2027 2028 and Thereafter Future amortization expense $ 351.5 $ 72.0 $ 91.1 $ 77.4 $ 55.6 $ 28.5 $ 26.9

Debt (Tables)

Debt (Tables)	3 Months Ended
	Oct. 31, 2022
Debt Disclosure [Abstract]
Convertible senior notes details	The following table presents details of our Notes (number of shares in millions): Conversion Rate per $1,000 Principal Initial Conversion Price Convertible Date Initial Number of Shares 2023 Notes 11.2635 $ 88.78 April 1, 2023 19.1 2025 Notes 10.0806 $ 99.20 March 1, 2025 20.1
Components of convertible senior notes	The following table sets forth the components of the Notes (in millions): October 31, 2022 July 31, 2022 2023 Notes 2025 Notes Total 2023 Notes 2025 Notes Total Liability component: Principal $ 1,691.9 $ 1,999.4 $ 3,691.3 $ 1,691.9 $ 1,999.4 $ 3,691.3 Less: debt discount and debt issuance costs, net of amortization (1.9) (10.8) (12.7) (2.6) (11.9) (14.5) Net carrying amount $ 1,690.0 $ 1,988.6 $ 3,678.6 $ 1,689.3 $ 1,987.5 $ 3,676.8
Interest expense recognized related to the convertible senior notes	The following table sets forth interest expense recognized related to the Notes (dollars in millions): Three Months Ended October 31, 2022 2021 2023 Notes 2025 Notes Total 2023 Notes 2025 Notes Total Contractual interest expense $ 3.2 $ 1.8 $ 5.0 $ 3.2 $ 1.9 $ 5.1 Amortization of debt issuance costs 0.7 1.1 1.8 0.7 1.1 1.8 Total interest expense $ 3.9 $ 2.9 $ 6.8 $ 3.9 $ 3.0 $ 6.9 Effective interest rate 0.9 % 0.6 % 0.9 % 0.6 %
Note hedges details	The following table presents details of our Note Hedges (in millions): Initial Number of Shares Aggregate Purchase 2023 Note Hedges 19.1 $ 332.0 2025 Note Hedges 20.1 $ 370.8
Warrants details	The following table presents details of our Warrants (in millions, except per share data): Initial Number Strike Price Aggregate 2023 Warrants 19.1 $ 139.27 $ 145.4 2025 Warrants 20.1 $ 136.16 $ 202.8

Commitments and Contingencies_2

Commitments and Contingencies (Tables)	3 Months Ended
	Oct. 31, 2022
Manufacturing purchase commitments
Aggregate Future Purchase Commitments
Schedule of future non-cancelable purchase commitments for inventory and cloud services	The following table presents details of the aggregate future minimum or fixed purchase commitments under these arrangements, excluding obligations under contracts that we can cancel as of October 31, 2022 (in millions): Fiscal years ending July 31, Total Remaining 2023 2024 2025 2026 2027 2028 and Thereafter Manufacturing purchase commitments $ 319.7 $ 189.7 $ 55.0 $ 35.0 $ 40.0 $ — $ —
Other purchase commitments
Aggregate Future Purchase Commitments
Schedule of future non-cancelable purchase commitments for inventory and cloud services	The following table presents details of the aggregate future non-cancelable purchase commitments under these agreements as of October 31, 2022 (in millions): Fiscal years ending July 31, Total Remaining 2023 2024 2025 2026 2027 2028 and Thereafter Other purchase commitments $ 1,801.4 $ 58.1 $ 357.6 $ 413.9 $ 516.3 $ 454.7 $ 0.8

Equity Award Plans (Tables)

Equity Award Plans (Tables)	3 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of restricted stock unit (“RSU”) and performance-based stock unit (“PSU”) activities	The following table summarizes the RSU and PSU activity under our stock plans during the three months ended October 31, 2022 (in millions, except per share amounts): RSUs Outstanding PSUs Outstanding Number of Shares Weighted-Average Grant-Date Fair Value Per Share Aggregate Intrinsic Value Number of Shares Weighted-Average Grant-Date Fair Value Per Share Aggregate Intrinsic Value Balance—July 31, 2022 14.8 $ 115.51 $ 2,456.9 3.1 $ 106.38 $ 513.7 Granted (1) 1.0 $ 174.04 2.6 $ 140.41 Vested (1.9) $ 99.25 (1.1) $ 117.42 Forfeited (0.4) $ 113.23 (0.1) $ 124.01 Balance—October 31, 2022 13.5 $ 122.57 $ 2,311.7 4.5 $ 123.10 $ 772.7 ______________ (1) For PSUs, shares granted represent the aggregate maximum number of shares that may be earned and issued with respect to these awards over their full terms.
Schedule of assumptions used and resulting grant-date fair values of our PSUs	The following table summarizes the assumptions used and the grant-date fair value of these PSUs granted: Three Months Ended October 31, 2022 2021 Volatility 39.6% - 44.8% 36.0% - 38.0% Expected term (in years) 1.0 - 4.0 1.9 - 3.0 Dividend yield 0.0 % 0.0 % Risk-free interest rate 3.2% - 3.6% 0.2% - 0.4% Grant-date fair value per share $105.60 - $280.41 $137.16 - $140.22
Schedule of performance stock option ("PSO") activity	The following table summarizes the PSO activity under our stock plans during the three months ended October 31, 2022 (in millions, except per share amounts): PSOs Outstanding Number of Shares Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Balance—July 31, 2022 8.0 $ 64.85 3.2 $ 809.3 Balance—October 31, 2022 8.0 $ 64.85 2.9 $ 851.0 Exercisable—October 31, 2022 8.0 $ 64.85 2.9 $ 851.0
Schedule of allocation of share-based compensation expense	The following table summarizes share-based compensation included in costs and expenses (in millions): Three Months Ended October 31, 2022 2021 Cost of product revenue $ 2.4 $ 2.3 Cost of subscription and support revenue 28.8 26.7 Research and development 118.0 125.6 Sales and marketing 87.4 73.3 General and administrative 29.4 32.4 Total share-based compensation $ 266.0 $ 260.3

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	3 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Computation of basic and diluted net loss per share of common stock	The following table presents the computation of basic and diluted net income (loss) per share of common stock (in millions, except per share data): Three Months Ended October 31, 2022 2021 Net income (loss) $ 20.0 $ (103.6) Weighted-average shares used to compute net income (loss) per share, basic 299.8 292.9 Weighted-average effect of potentially dilutive securities: Convertible senior notes 17.8 — Warrants related to the issuance of convertible senior notes 7.8 — Employee equity incentive plans 13.0 — Weighted-average shares used to compute net income (loss) per share, diluted 338.4 292.9 Net income (loss) per share, basic $ 0.07 $ (0.35) Net income (loss) per share, diluted $ 0.06 $ (0.35)
Schedule of antidilutive securities excluded from the computation of net loss per share	The following securities were excluded from the computation of diluted net income (loss) per share of common stock as their effect would have been antidilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the applicable period (in millions): Three Months Ended October 31, 2022 2021 Convertible senior notes — 39.2 Warrants related to the issuance of convertible senior notes — 39.2 Employee equity incentive plans 2.7 34.5 Total 2.7 112.9

Other Income (Expense), Net (Ta

Other Income (Expense), Net (Tables)	3 Months Ended
	Oct. 31, 2022
Other Income and Expenses [Abstract]
Schedule of components of other income (expense), net	The following table sets forth the components of other income (expense), net (in millions): Three Months Ended October 31, 2022 2021 Interest income $ 29.4 $ 1.4 Foreign currency exchange gains (losses), net 4.4 (3.9) Other (7.8) 0.9 Total other income (expense), net $ 26.0 $ (1.6)

Description of Business and S_3

Description of Business and Summary of Significant Accounting Policies (Details)	Sep. 13, 2022 $ / shares	Oct. 31, 2022 $ / shares	Jul. 31, 2022 $ / shares
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Stock split ratio	3
Common stock, par value (in usd per share)	$ 0.001	$ 0.0001	$ 0.0001

Revenue (Disaggregation of Reve

Revenue (Disaggregation of Revenue (Geographic Theater) (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Disaggregation of Revenue
Revenue:	$ 1,563.4	$ 1,247.4
United States
Disaggregation of Revenue
Revenue:	1,006.3	811.7
Other Americas
Disaggregation of Revenue
Revenue:	64.4	55
Total Americas
Disaggregation of Revenue
Revenue:	1,070.7	866.7
Europe, the Middle East, and Africa (“EMEA”)
Disaggregation of Revenue
Revenue:	307.9	233.8
Asia Pacific and Japan (“APAC”)
Disaggregation of Revenue
Revenue:	$ 184.8	$ 146.9

Revenue (Disaggregation of Re_2

Revenue (Disaggregation of Revenue (Type of Revenue) (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Revenue:
Revenue:	$ 1,563.4	$ 1,247.4
Product
Revenue:
Revenue:	330	295.5
Subscription
Revenue:
Revenue:	764	578.8
Support
Revenue:
Revenue:	469.4	373.1
Subscription and support
Revenue:
Revenue:	$ 1,233.4	$ 951.9

Revenue (Deferred Revenue) (Det

Revenue (Deferred Revenue) (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenue recognized from opening deferred revenue balance	$ 1,100	$ 840

Revenue (Remaining Performance

Revenue (Remaining Performance Obligations) (Details) $ in Billions	Oct. 31, 2022 USD ($)
Remaining Performance Obligations, Expected Timing of Satisfaction
Remaining performance obligations	$ 8.3
Remaining Performance Obligations, Expected Timing of Satisfaction, Start Date: 2022-11-01
Remaining Performance Obligations, Expected Timing of Satisfaction
Remaining performance obligations	$ 4.2
Remaining performance obligations, expected timing of satisfaction, period	12 months

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Fair value, measurements, recurring - USD ($) $ in Millions	Oct. 31, 2022	Jul. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	$ 1,619.4	$ 1,464.2
Short-term investments	1,736.5	1,516
Long-term investments	2,094.7	1,051.9
Total prepaid expenses and other current assets	0.5	2.4
Total other assets	0.2	0.7
Total assets measured at fair value	5,451.3	4,035.2
Total accrued and other liabilities	51.4	32.4
Total other long-term liabilities	5.2	0.8
Total liabilities measured at fair value	56.6	33.2
Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	933.2	1,205.2
Short-term investments	0	0
Long-term investments	0	0
Total prepaid expenses and other current assets	0	0
Total other assets	0	0
Total assets measured at fair value	933.2	1,205.2
Total accrued and other liabilities	0	0
Total other long-term liabilities	0	0
Total liabilities measured at fair value	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	686.2	259
Short-term investments	1,736.5	1,516
Long-term investments	2,094.7	1,051.9
Total prepaid expenses and other current assets	0.5	2.4
Total other assets	0.2	0.7
Total assets measured at fair value	4,518.1	2,830
Total accrued and other liabilities	51.4	32.4
Total other long-term liabilities	5.2	0.8
Total liabilities measured at fair value	56.6	33.2
Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Short-term investments	0	0
Long-term investments	0	0
Total prepaid expenses and other current assets	0	0
Total other assets	0	0
Total assets measured at fair value	0	0
Total accrued and other liabilities	0	0
Total other long-term liabilities	0	0
Total liabilities measured at fair value	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	933.2	1,205.2
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	933.2	1,205.2
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Money market funds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	150.6	155.3
Short-term investments	213	116.4
Certificates of deposit | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Short-term investments	0	0
Certificates of deposit | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	150.6	155.3
Short-term investments	213	116.4
Certificates of deposit | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Short-term investments	0	0
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	338.5	69.1
Short-term investments	288.3	79
Commercial paper | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Short-term investments	0	0
Commercial paper | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	338.5	69.1
Short-term investments	288.3	79
Commercial paper | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Short-term investments	0	0
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	37.2	19.5
Short-term investments	661.4	505
Long-term investments	1,623.8	761.2
Corporate debt securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Short-term investments	0	0
Long-term investments	0	0
Corporate debt securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	37.2	19.5
Short-term investments	661.4	505
Long-term investments	1,623.8	761.2
Corporate debt securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Short-term investments	0	0
Long-term investments	0	0
U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	159.9	10
Short-term investments	546.9	798.2
Long-term investments	50.2	118.2
U.S. government and agency securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Short-term investments	0	0
Long-term investments	0	0
U.S. government and agency securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	159.9	10
Short-term investments	546.9	798.2
Long-term investments	50.2	118.2
U.S. government and agency securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Short-term investments	0	0
Long-term investments	0	0
Non-U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	5.1
Short-term investments	26.9	17.4
Long-term investments	52	0
Non-U.S. government and agency securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Short-term investments	0	0
Long-term investments	0	0
Non-U.S. government and agency securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	5.1
Short-term investments	26.9	17.4
Long-term investments	52	0
Non-U.S. government and agency securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Short-term investments	0	0
Long-term investments	0	0
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring Basis
Long-term investments	368.7	172.5
Asset-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Long-term investments	0	0
Asset-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Long-term investments	368.7	172.5
Asset-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Long-term investments	0	0
Foreign currency forward contracts
Fair Value, Assets and Liabilities Measured on Recurring Basis
Foreign currency forward contracts, assets, current	0.5	2.4
Foreign currency forward contracts, assets, noncurrent	0.2	0.7
Foreign currency forward contracts, liability, current	51.4	32.4
Foreign currency forward contracts, liability, noncurrent	5.2	0.8
Foreign currency forward contracts | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Foreign currency forward contracts, assets, current	0	0
Foreign currency forward contracts, assets, noncurrent	0	0
Foreign currency forward contracts, liability, current	0	0
Foreign currency forward contracts, liability, noncurrent	0	0
Foreign currency forward contracts | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Foreign currency forward contracts, assets, current	0.5	2.4
Foreign currency forward contracts, assets, noncurrent	0.2	0.7
Foreign currency forward contracts, liability, current	51.4	32.4
Foreign currency forward contracts, liability, noncurrent	5.2	0.8
Foreign currency forward contracts | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Foreign currency forward contracts, assets, current	0	0
Foreign currency forward contracts, assets, noncurrent	0	0
Foreign currency forward contracts, liability, current	0	0
Foreign currency forward contracts, liability, noncurrent	$ 0	$ 0

Cash Equivalents and Investme_3

Cash Equivalents and Investments (Available-for-Sale Securities) (Details) - USD ($) $ in Millions	Oct. 31, 2022	Jul. 31, 2022
Debt Securities, Available-for-sale
Amortized Cost	$ 4,568.7
Fair Value	4,517.4
Cash equivalents:
Debt Securities, Available-for-sale
Amortized Cost	686.3	$ 258.9
Unrealized Gains	0	0.1
Unrealized Losses	(0.1)	0
Fair Value	686.2	259
Cash equivalents: | Certificates of deposit
Debt Securities, Available-for-sale
Amortized Cost	150.6	155.3
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	150.6	155.3
Cash equivalents: | Commercial paper
Debt Securities, Available-for-sale
Amortized Cost	338.5	69.1
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	338.5	69.1
Cash equivalents: | Corporate debt securities
Debt Securities, Available-for-sale
Amortized Cost	37.3	19.5
Unrealized Gains	0	0
Unrealized Losses	(0.1)	0
Fair Value	37.2	19.5
Cash equivalents: | U.S. government and agency securities
Debt Securities, Available-for-sale
Amortized Cost	159.9	10
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	159.9	10
Cash equivalents: | Non-U.S. government and agency securities
Debt Securities, Available-for-sale
Amortized Cost		5
Unrealized Gains		0.1
Unrealized Losses		0
Fair Value		5.1
Investments:
Debt Securities, Available-for-sale
Amortized Cost	3,882.4	2,591.5
Unrealized Gains	0.4	1.6
Unrealized Losses	(51.6)	(25.2)
Fair Value	3,831.2	2,567.9
Investments: | Certificates of deposit
Debt Securities, Available-for-sale
Amortized Cost	213.3	116.5
Unrealized Gains	0	0
Unrealized Losses	(0.3)	(0.1)
Fair Value	213	116.4
Investments: | Commercial paper
Debt Securities, Available-for-sale
Amortized Cost	289.4	79.1
Unrealized Gains	0	0
Unrealized Losses	(1.1)	(0.1)
Fair Value	288.3	79
Investments: | Corporate debt securities
Debt Securities, Available-for-sale
Amortized Cost	2,321.6	1,276.8
Unrealized Gains	0.4	1.3
Unrealized Losses	(36.8)	(11.9)
Fair Value	2,285.2	1,266.2
Investments: | U.S. government and agency securities
Debt Securities, Available-for-sale
Amortized Cost	605.3	928.1
Unrealized Gains	0	0.1
Unrealized Losses	(8.2)	(11.8)
Fair Value	597.1	916.4
Investments: | Non-U.S. government and agency securities
Debt Securities, Available-for-sale
Amortized Cost	80	17.6
Unrealized Gains	0	0
Unrealized Losses	(1.1)	(0.2)
Fair Value	78.9	17.4
Investments: | Asset-backed securities
Debt Securities, Available-for-sale
Amortized Cost	372.8	173.4
Unrealized Gains	0	0.2
Unrealized Losses	(4.1)	(1.1)
Fair Value	$ 368.7	$ 172.5

Cash Equivalents and Investme_4

Cash Equivalents and Investments (Available-for-sale Debt Securities Narrative) (Details) - USD ($) $ in Millions	Oct. 31, 2022	Jul. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Gross unrealized losses for available-for-sale debt securities in a continuous unrealized loss position for less than 12 months	$ 45.7	$ 24.8
Available-for-sale debt securities in a continuous unrealized loss position for less than 12 months	$ 3,500	$ 2,000

Cash Equivalents and Investme_5

Cash Equivalents and Investments (Available-for-Sale Securities, Contractual Maturities) (Details) $ in Millions	Oct. 31, 2022 USD ($)
Amortized Cost
Due within one year	$ 2,438.8
Due between one and three years	2,001.9
Due between three to five years	106.9
Due between five to ten years	21.1
Amortized Cost	4,568.7
Fair Value
Due within one year	2,422.7
Due between one and three years	1,968.5
Due between three to five years	105.4
Due between five to ten years	20.8
Fair Value	$ 4,517.4

Cash Equivalents and Investme_6

Cash Equivalents and Investments (Marketable Equity Securities) (Details) - Cash and cash equivalents - Marketable equity securities - Money market funds - USD ($)	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Jul. 31, 2022
Marketable Equity Securities
Carrying value	$ 933,200,000		$ 1,200,000,000
Unrealized gains or losses recognized	$ 0	$ 0

Financing Receivables (Details)

Financing Receivables (Details) - USD ($) $ in Millions	Oct. 31, 2022	Jul. 31, 2022
Receivables [Abstract]
Short-term financing receivables, gross	$ 155.5	$ 112.6
Allowance for credit losses	(1.8)	(1.3)
Short-term financing receivables, net	153.7	111.3
Long-term financing receivables, gross	165.2	194.6
Allowance for credit losses	(3.1)	(2.5)
Long-term financing receivables, net	$ 162.1	$ 192.1

Derivative Instruments (Details

Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Oct. 31, 2022	Jul. 31, 2022
Derivative
Total notional amount	$ 1,300	$ 856.9
Unrealized losses in AOCI related to cash flow hedges	52.5	24.8
Losses expected to be recognized into earnings within the next 12 months	$ 44.2	$ 22
Foreign Exchange Contract
Derivative
Maximum contract term of cash flow hedge	24 months

Intangible Assets (Purchased In

Intangible Assets (Purchased Intangible Assets by Major Class) (Details) - USD ($) $ in Millions	Oct. 31, 2022	Jul. 31, 2022
Intangible assets subject to amortization:
Total intangible assets subject to amortization, gross carrying amount	$ 795	$ 795
Total purchased intangible assets, gross carrying amount	798.9	798.9
Accumulated amortization	(443.5)	(414.4)
Total intangible assets subject to amortization, net carrying amount	351.5	380.6
Total purchased intangible assets, net carrying amount	355.4	384.5
In-process research and development
Intangible assets not subject to amortization:
In-process research and development	3.9	3.9
Developed technology
Intangible assets subject to amortization:
Total intangible assets subject to amortization, gross carrying amount	600.7	600.7
Accumulated amortization	(371.2)	(347.9)
Total intangible assets subject to amortization, net carrying amount	229.5	252.8
Customer relationships
Intangible assets subject to amortization:
Total intangible assets subject to amortization, gross carrying amount	172.7	172.7
Accumulated amortization	(57.7)	(52.2)
Total intangible assets subject to amortization, net carrying amount	115	120.5
Acquired intellectual property
Intangible assets subject to amortization:
Total intangible assets subject to amortization, gross carrying amount	11.3	11.3
Accumulated amortization	(5)	(4.8)
Total intangible assets subject to amortization, net carrying amount	6.3	6.5
Trade name and trademarks
Intangible assets subject to amortization:
Total intangible assets subject to amortization, gross carrying amount	9.4	9.4
Accumulated amortization	(9.4)	(9.4)
Total intangible assets subject to amortization, net carrying amount	0	0
Other
Intangible assets subject to amortization:
Total intangible assets subject to amortization, gross carrying amount	0.9	0.9
Accumulated amortization	(0.2)	(0.1)
Total intangible assets subject to amortization, net carrying amount	$ 0.7	$ 0.8

Intangible Assets (Amortization

Intangible Assets (Amortization Expense) (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 29.1	$ 31.8

Intangible Assets (Future Amort

Intangible Assets (Future Amortization Expense of Intangible Assets) (Details) - USD ($) $ in Millions	Oct. 31, 2022	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remaining 2023	$ 72
2024	91.1
2025	77.4
2026	55.6
2027	28.5
2028 and Thereafter	26.9
Total intangible assets subject to amortization, net carrying amount	$ 351.5	$ 380.6

Debt (Additional Details) (Deta

Debt (Additional Details) (Details) $ in Billions	Jun. 03, 2020 USD ($) day	Jul. 31, 2018 USD ($) day	Oct. 31, 2022 USD ($)	Jul. 31, 2022 USD ($)
2023 Notes
Debt Instrument, Redemption
Aggregate principal amount | $		$ 1.7
Contractual interest rate (in percentage)		0.75%
Repurchase price as percentage of principal amount in event of change (in percentage)		100%
2023 Notes | Level 2
Debt Instrument, Redemption
Fair value of convertible senior notes | $			$ 3.3	$ 3.2
2025 Notes
Debt Instrument, Redemption
Aggregate principal amount | $	$ 2
Contractual interest rate (in percentage)	0.375%
Threshold percentage of stock price trigger (in percentage)	130%
Threshold trading days (in days)	20
Threshold consecutive trading days (in days)	30
Redemption price (in percentage)	100%
Repurchase price as percentage of principal amount in event of change (in percentage)	100%
2025 Notes | Level 2
Debt Instrument, Redemption
Fair value of convertible senior notes | $			$ 3.5	$ 3.5
Option to Convert - 2023 Notes
Debt Instrument, Redemption
Threshold percentage of stock price trigger (in percentage)		130%
Threshold trading days (in days)		20
Threshold consecutive trading days (in days)		30
Threshold business days, per $1,000 principal (in days)		5
Threshold consecutive trading days, per $1,000 principal (in days)		5
Threshold percentage of notes price trigger, per $1,000 principal (in percentage)		98%
Option to Convert - 2025 Notes
Debt Instrument, Redemption
Threshold percentage of stock price trigger (in percentage)	130%
Threshold trading days (in days)	20
Threshold consecutive trading days (in days)	30
Threshold business days, per $1,000 principal (in days)	5
Threshold consecutive trading days, per $1,000 principal (in days)	5
Threshold percentage of notes price trigger, per $1,000 principal (in percentage)	98%

Debt (Details of Our Notes)

Debt (Details of Our Notes) shares in Millions	Jun. 03, 2020 shares $ / shares	Jul. 31, 2018 shares $ / shares
2023 Notes
Debt Instrument
Initial conversion rate (in shares per $1,000 principal amount)		11.2635
Initial conversion price (in usd per share) | $ / shares		$ 88.78
Number of common stock convertible at initial conversion rate (in shares) | shares		19.1
2025 Notes
Debt Instrument
Initial conversion rate (in shares per $1,000 principal amount)	10.0806
Initial conversion price (in usd per share) | $ / shares	$ 99.20
Number of common stock convertible at initial conversion rate (in shares) | shares	20.1

Debt (Components of Convertible

Debt (Components of Convertible Senior Notes) (Details) - USD ($) $ in Millions	Oct. 31, 2022	Jul. 31, 2022
Debt Instrument, Redemption
Principal	$ 3,691.3	$ 3,691.3
Less: debt discount and debt issuance costs, net of amortization	(12.7)	(14.5)
Net carrying amount	3,678.6	3,676.8
2023 Notes
Debt Instrument, Redemption
Principal	1,691.9	1,691.9
Less: debt discount and debt issuance costs, net of amortization	(1.9)	(2.6)
Net carrying amount	1,690	1,689.3
2025 Notes
Debt Instrument, Redemption
Principal	1,999.4	1,999.4
Less: debt discount and debt issuance costs, net of amortization	(10.8)	(11.9)
Net carrying amount	$ 1,988.6	$ 1,987.5

Debt (Schedule of Interest Expe

Debt (Schedule of Interest Expense Recognized) (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Debt Instrument, Redemption
Contractual interest expense	$ 5	$ 5.1
Amortization of debt issuance costs	1.8	1.8
Total interest expense	6.8	6.9
2023 Notes
Debt Instrument, Redemption
Contractual interest expense	3.2	3.2
Amortization of debt issuance costs	0.7	0.7
Total interest expense	$ 3.9	$ 3.9
Effective interest rate	0.90%	0.90%
2025 Notes
Debt Instrument, Redemption
Contractual interest expense	$ 1.8	$ 1.9
Amortization of debt issuance costs	1.1	1.1
Total interest expense	$ 2.9	$ 3
Effective interest rate	0.60%	0.60%

Debt (Note Hedges) (Details)

Debt (Note Hedges) (Details) - USD ($) shares in Millions, $ in Millions	Jun. 03, 2020	Jul. 31, 2018
2023 Note Hedges
Schedule of Note Hedge Transactions
Shares of common stock covered by note hedges (in shares)		19.1
Aggregate amount paid to purchase note hedges - additional paid-in capital		$ 332
2025 Note Hedges
Schedule of Note Hedge Transactions
Shares of common stock covered by note hedges (in shares)	20.1
Aggregate amount paid to purchase note hedges - additional paid-in capital	$ 370.8

Debt (Warrants) (Details)

Debt (Warrants) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	Jun. 03, 2020	Jul. 31, 2018
2023 Warrants
Class of Warrant or Right
Warrants sold, shares authorized to sell to counterparties (in shares)		19.1
Strike price of warrants (in usd per share)		$ 139.27
Proceeds from issuance of warrants		$ 145.4
2025 Warrants
Class of Warrant or Right
Warrants sold, shares authorized to sell to counterparties (in shares)	20.1
Strike price of warrants (in usd per share)	$ 136.16
Proceeds from issuance of warrants	$ 202.8

Debt (Revolving Credit Facility

Debt (Revolving Credit Facility) (Details) - Revolving credit facility - USD ($)	Sep. 04, 2018	Oct. 31, 2022
Line of Credit Facility
Current borrowing capacity	$ 400,000,000
Option for additional borrowing capacity	$ 350,000,000
Revolving credit facility amount outstanding		$ 0
Minimum maturity date term criteria
Line of Credit Facility
Number of days prior to maturity of 2023 Notes (in days)	91 days
Minimum maturity date term, cash and cash equivalents balance criteria
Line of Credit Facility
Amount added to outstanding principal amount of 2023 Notes in minimum maturity date criteria	$ 400,000,000
Minimum
Line of Credit Facility
Commitment fee rate on undrawn amounts (in percentage)	0.125%
Maximum
Line of Credit Facility
Commitment fee rate on undrawn amounts (in percentage)	0.25%
Base Rate | Minimum
Line of Credit Facility
Spread on variable rate	0%
Base Rate | Maximum
Line of Credit Facility
Spread on variable rate	0.75%
LIBOR | Minimum
Line of Credit Facility
Spread on variable rate	1%
LIBOR | Maximum
Line of Credit Facility
Spread on variable rate	1.75%

Commitments and Contingencies_3

Commitments and Contingencies (Manufacturing Purchase Commitments) (Details) - Manufacturing purchase commitments $ in Millions	Oct. 31, 2022 USD ($)
Aggregate Future Purchase Commitments
Remaining 2023	$ 189.7
2024	55
2025	35
2026	40
2027	0
2028 and Thereafter	0
Total	$ 319.7

Commitments and Contingencies_4

Commitments and Contingencies (Other Purchase Commitments) (Details) $ in Millions	3 Months Ended
	Oct. 31, 2022 USD ($)
Other purchase commitments
Aggregate Future Purchase Commitments
Remaining 2023	$ 58.1
2024	357.6
2025	413.9
2026	516.3
2027	454.7
2028 and Thereafter	0.8
Total	1,801.4
Service provider
Aggregate Future Purchase Commitments
Minimum purchase commitment	$ 160.6

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) $ in Millions	1 Months Ended			3 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Dec. 31, 2020	Oct. 31, 2022	Oct. 31, 2021	Feb. 28, 2019
Equity [Abstract]
Share repurchase, authorized amount				$ 3,300		$ 1,000
Stock repurchase program, increase in authorized amount	$ 915	$ 676.1	$ 700
Repurchases of common stock				22.7	$ 0
Stock repurchase, remaining authorized repurchase amount				$ 1,000

Equity Award Plans (Restricted

Equity Award Plans (Restricted Stock Unit (RSU) and Performance-Based Stock Unit (PSU) Activities) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Oct. 31, 2022	Jul. 31, 2022
RSUs
RSUs and PSUs, Outstanding Roll Forward
Balance, beginning (in shares)	14.8
Granted (in shares)	1
Vested (in shares)	(1.9)
Forfeited (in shares)	(0.4)
Balance, ending (in shares)	13.5
RSUs and PSUs, Outstanding, Weighted-Average Grant-Date Fair Value Per Share
Balance, beginning (in usd per share)	$ 115.51
Granted (in usd per share)	174.04
Vested (in usd per share)	99.25
Forfeited (in usd per share)	113.23
Balance, ending (in usd per share)	$ 122.57
RSUs and PSUs, Additional Disclosures
Aggregate intrinsic value	$ 2,311.7	$ 2,456.9
PSUs
RSUs and PSUs, Outstanding Roll Forward
Balance, beginning (in shares)	3.1
Granted (in shares)	2.6
Vested (in shares)	(1.1)
Forfeited (in shares)	(0.1)
Balance, ending (in shares)	4.5
RSUs and PSUs, Outstanding, Weighted-Average Grant-Date Fair Value Per Share
Balance, beginning (in usd per share)	$ 106.38
Granted (in usd per share)	140.41
Vested (in usd per share)	117.42
Forfeited (in usd per share)	124.01
Balance, ending (in usd per share)	$ 123.10
RSUs and PSUs, Additional Disclosures
Aggregate intrinsic value	$ 772.7	$ 513.7

Equity Award Plans (Additional

Equity Award Plans (Additional Information) (Details) shares in Millions	3 Months Ended
	Oct. 31, 2022 day $ / shares shares	Oct. 31, 2021 shares
RSUs
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	1
RSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	3 years
RSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	4 years
PSUs
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	2.6
PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	1 year
PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	4 years
PSUs with both a service condition and a market condition
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	0.8
Threshold consecutive trading days (in days) | day	30
PSUs with both a service condition and a market condition | Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award
Target stock price (in usd per share) | $ / shares	$ 233.33
Award vesting percent	25%
PSUs with both a service condition and a market condition | Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award
Target stock price (in usd per share) | $ / shares	$ 266.67
Award vesting percent	25%
PSUs with both a service condition and a market condition | Share-Based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award
Target stock price (in usd per share) | $ / shares	$ 300
Award vesting percent	25%
PSUs with both a service condition and a market condition | Share-based Payment Arrangement, Tranche Four
Share-based Compensation Arrangement by Share-based Payment Award
Target stock price (in usd per share) | $ / shares	$ 333.33
Award vesting percent	25%
PSUs with both a service condition and a market condition | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	3 years
PSUs with both a service condition and a market condition | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	4 years
PSUs subject to service, performance, and market conditions
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	1.6	0.6
Number of shares authorized (in shares)	2.3
PSUs subject to service, performance, and market conditions | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Service period	1 year
PSUs subject to service, performance, and market conditions | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Service period	3 years
PSOs | Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting percent	25%
PSOs | Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting percent	25%
PSOs | Share-Based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting percent	25%
PSOs | Share-based Payment Arrangement, Tranche Four
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting percent	25%
PSOs | Minimum | Fiscal Year 2018
Share-based Compensation Arrangement by Share-based Payment Award
Service period	7 years
PSOs | Minimum | Fiscal Year 2019
Share-based Compensation Arrangement by Share-based Payment Award
Service period	7 years
PSOs | Maximum | Fiscal Year 2018
Share-based Compensation Arrangement by Share-based Payment Award
Service period	7 years 6 months
PSOs | Maximum | Fiscal Year 2019
Share-based Compensation Arrangement by Share-based Payment Award
Service period	7 years 6 months

Equity Award Plans (Valuation A

Equity Award Plans (Valuation Assumptions) (Details) - PSUs subject to market conditions - $ / shares	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award
Expected minimum volatility rate (in percentage)	39.60%	36%
Expected maximum volatility rate (in percentage)	44.80%	38%
Expected dividend rate (in percentage)	0%	0%
Minimum risk-free interest rate (in percentage)	3.20%	0.20%
Maximum risk-free interest rate (in percentage)	3.60%	0.40%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Expected term (in years)	1 year	1 year 10 months 24 days
Share price	$ 105.60	$ 137.16
Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Expected term (in years)	4 years	3 years
Share price	$ 280.41	$ 140.22

Equity Award Plans (Performance

Equity Award Plans (Performance Stock Option (PSO) Activities) (Details) - PSOs - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended	6 Months Ended
	Oct. 31, 2022	Jan. 31, 2022	Jul. 31, 2022
PSOs, Outstanding Roll Forward
Balance, beginning (in shares)	8
Balance, ending (in shares)	8
Options exercisable (in shares)	8
PSOs, Outstanding, Weighted-Average Exercise Price Roll Forward
Balance, beginning (in usd per share)	$ 64.85
Balance, ending (in usd per share)	64.85
Options exercisable, weighted-average exercise price (in usd per share)	$ 64.85
PSOs, Additional Disclosures
Weighted-average remaining contractual life (in years)	2 years 10 months 24 days	3 years 2 months 12 days
Options exercisable, weighted-average remaining contractual term (in years)	2 years 10 months 24 days
Aggregate intrinsic value	$ 851		$ 809.3
Options exercisable, aggregate intrinsic value	$ 851

Equity Award Plans (Allocation

Equity Award Plans (Allocation of Share-Based Compensation Expense) (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	$ 266	$ 260.3
Cost of revenue | Product
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	2.4	2.3
Cost of revenue | Subscription and support
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	28.8	26.7
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	118	125.6
Sales and marketing
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	87.4	73.3
General and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	$ 29.4	$ 32.4

Equity Award Plans (Allocatio_2

Equity Award Plans (Allocation of Share-based Compensation, Additional Information) (Details) $ in Billions	3 Months Ended
	Oct. 31, 2022 USD ($)
Share-Based Payment Arrangement [Abstract]
Unvested share-based awards not yet recognized	$ 2
Weighted-average recognition period	2 years 6 months

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Effective income tax rate (in percentage)	41.90%	(13.60%)

Net Income (Loss) Per Share (Co

Net Income (Loss) Per Share (Computation of Basic and Diluted Net Loss Per Share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Earnings Per Share [Abstract]
Net income (loss)	$ 20	$ (103.6)
Weighted-average shares used to compute net income (loss) per share, basic (in shares)	299.8	292.9
Weighted-average effect of potentially dilutive securities
Convertible senior notes (in shares)	17.8	0
Warrants related to the issuance of convertible senior notes (in shares)	7.8	0
Employee equity incentive plans (in shares)	13	0
Weighted-average shares used to compute net income (loss) per share, diluted (in shares)	338.4	292.9
Net income (loss) per share, basic (in usd per share)	$ 0.07	$ (0.35)
Net income (loss) per share, diluted (in usd per share)	$ 0.06	$ (0.35)

Net Income (Loss) Per Share (Sc

Net Income (Loss) Per Share (Schedule of Antidilutive Securities Excluded from Computation) (Details) - shares shares in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities (in shares)	2.7	112.9
Convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities (in shares)	0	39.2
Warrants related to the issuance of convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities (in shares)	0	39.2
Employee equity incentive plans
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities (in shares)	2.7	34.5

Other Income (Expense), Net (De

Other Income (Expense), Net (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Other Income and Expenses [Abstract]
Interest income	$ 29.4	$ 1.4
Foreign currency exchange gains (losses), net	4.4	(3.9)
Other	(7.8)	0.9
Total other income (expense), net	$ 26	$ (1.6)

Subsequent Event (Details)

Subsequent Event (Details) - Subsequent Event - Cider Security Ltd. $ in Millions	Nov. 17, 2022 USD ($)
Subsequent Event
Total purchase consideration	$ 250
Cash	194.6
Fair value of replacement awards	$ 55.4